Retinal Manifestations of Autoimmune and Inflammatory Disease

Pantanelli, Seth; Khalifa, Yousuf M.

doi:10.1097/iio.0b013e31823bbbe9

Cited by 4 publications

(3 citation statements)

References 87 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is generally observed in patients with a high level of antiphospholipid antibody. In our study, the frequency of SLE was 1.4% (n=2) (24,25). The levels of antiphospholipid antibody were normal in these cases.…”

Section: Discussionmentioning

confidence: 79%

Frequency of Lung Disease in Patients Diagnosed with Uveitis

Kılıç¹,

Kanbay²,

Şentürk³

et al. 2015

Erciyes Med J

View full text Add to dashboard Cite

Objective: To identify the etiologic and demographic features of uveitis cases admitted to the Ankara Ataturk Education and Research Hospital in Turkey and to determine the frequency of lung disease in these cases. Materials and Methods:The records of 140 uveitis cases followed up in our hospital were retrospectively examined. The patients underwent systemic and complete ophthalmologic examinations. Laboratory and radiological examinations were performed for the etiology of uveitis. The age and sex of the patients, anatomic localization, and the etiology of uveitis were evaluated. Results:The mean age±standard deviation of 140 patients included in the study was 39.6±14.9 years. The proportion of female/male was 61 (43.6%)/79 (56.4%). The cases were put into 4 groups according to their anatomical localizations: anterior uveitis (48.6%; n=68), posterior uveitis (28.6%; n=40), panuveitis (31.1%; n=31), and intermediate uveitis (0.7%; n=1). Idiopathic uveitis accounted for the majority of all cases (n=69, 49.3%). Behcet's disease was the second most common diagnosis (n=41, 29.3%), followed by uveitis associated with sarcoidosis (n=8, 5.7%). Anterior uveitis was the most common anatomical localization (n=68, 48.6%) and posterior uveitis followed it (n=40, 28.6%). Conclusion:The etiologic distribution of uveitis varies with the geographical location. The most frequently seen form of uveitis in our clinic is idiopathic. Among diseases leading to uveitis and primarily affecting the lung, Behcet's disease comes first and it is followed by sarcoidosis.

show abstract

Section: Discussionmentioning

confidence: 79%

Frequency of Lung Disease in Patients Diagnosed with Uveitis

Kılıç¹,

Kanbay²,

Şentürk³

et al. 2015

Erciyes Med J

View full text Add to dashboard Cite

show abstract

“…At the same time, hypopyon nowadays is less commonly seen because of earlier and more aggressive treatments. In the convalescent period of uveitis with hypopyon, slightly thickened pigment particles presenting as multiple dark brown spots can be seen in the inferior angle [17,21].…”

Section: Anterior Segment Involvementmentioning

confidence: 99%

“…In addition to this, BD is the only systemic vasculitis affecting small-and medium-sized arteries and also veins. Venous and capillary dilatation with engorgement may also be seen (Figure 4) [21].…”

Section: Posterior Segment Involvementmentioning

confidence: 99%

Ocular Manifestations of Behçet’s Disease

Şahlı¹,

Gurbuz-Koz²

2017

Behcet's Disease

View full text Add to dashboard Cite

Behçet's disease (BD) is a multisystemic autoimmune inflammatory disorder characterized by oral aphthous lesions, genital ulcerations, iridocyclitis with hypopyon, and skin lesions. While ocular manifestations occur in nearly 50% of the patients with Behçet's disease, ocular involvement is the initial manifestation in only less than 20% of the patients. Ocular Behçet's disease clinically presents iridocyclitis with or without hypopyon, vitritis, retinitis, occlusive retinal vasculitis, and cystoid macular edema. However, anterior uveitis is usually the only initial ocular manifestation; the most common form is panuveitis. The usual course of the disease is characterized by recurrent inflammatory periods. Recurrent inflammatory attacks may result in irreversible damage and significant visual loss. Early and effective treatment is required to prevent ocular morbidity. Recent developments in the treatment of ocular Behçet's disease like biological agents are promising with a rapid effect and high remission rates.

show abstract